Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

Sujoy Ghosh,1 Shailesh Trivedi,2 Debmalya Sanyal,3 KD Modi,4 Sandeep Kharb5 1Department of Endocrinology, The Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, West Bengal, 2Anand Hospital, Vadodara, Gujarat, 3Department of Endocrinology, KPC Medical College, Kolkata, West...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ghosh S, Trivedi S, Sanyal D, Modi KD, Kharb S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
teneligliptin
DPP4 inhibitor
Type 2 diabetes mellitus
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/5c328f2ca75d4372b8d57ab03c1b0606
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares